Also known as: GRIN1 Sequencing, Autosomal Dominant Mental Retardation Type 8 (MRD8) Test
Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3 to 4 Weeks
GRIN1 Gene Sequencing Test in UAE | 2800 AED | Comprehensive NGS Analysis
Executive Summary & Core Metrics
- Clinical Focus: This comprehensive genetic test screens the GRIN1 gene for autosomal dominant mental retardation type 8 (MRD8), utilizing Next-Generation Sequencing (NGS) technology for definitive molecular diagnosis.
- Accuracy Guarantee: >99.9% diagnostic sensitivity achieved via ISO 9001:2015 accredited NGS processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Mandatory pre-test genetic counselling included. Post-test telephonic guidance provided by DHA-licensed genetic specialists for result interpretation.
- Insurance: Direct billing verification available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The GRIN1 gene test screens for pathogenic variants causing severe neurodevelopmental disorders, including autosomal dominant mental retardation type 8 (MRD8), characterized by intellectual disability, epilepsy, and movement disorders. Unlike outdated single-gene Sanger screening, our comprehensive NGS panel offers full coding region coverage and splice site analysis, detecting copy number variations (CNVs) otherwise missed by inferior methodologies.
| Diagnostic Metrics | Our NGS Protocol (UAE) | Closest Alternative (Standard Exome) |
|---|---|---|
| Analytical Sensitivity | >99.9% (Single Nucleotide & Indels) | ~95% (Variant Calling Dependent) |
| CNV Detection | Included (High-Depth Coverage Algorithm) | Absent (Requires adjunctive MLPA) |
| Reporting Turnaround | 3 to 4 Weeks (DHA-Compliant Urgency) | 8 to 12 Weeks |
Physician Insight & Safety Protocols
Clinical Correlative Note from Lina Osama Zaki Quteineh (DHA: 9294403): "A positive GRIN1 variant confirms a molecular diagnosis, providing closure to a diagnostic odyssey and guiding prognosis regarding refractory epilepsy and cortical visual impairment. A negative result necessitates a broader whole-genome evaluation to identify polygenic or mitochondrial contributions to the phenotype. This test is not a standalone diagnostic indicator of intelligence quotient."
Safety Exclusion Criteria & Emergency Red Flags
- Sample Integrity: Test requires high-molecular-weight DNA. Prior allogeneic bone marrow transplantation or recent blood transfusion (within 2 weeks) may result in false genotyping.
- ER Red Flags: Proceed to emergency department immediately if the patient develops status epilepticus (seizure lasting more than 5 minutes), severe aspiration pneumonia, or acute dystonic reaction, irrespective of pending genetic results.
- Pre-Analytical: Strictly adhere to the pre-test genetic counselling protocol (pedigree chart mandatory per UAE regulations for minors).
Pre-Test Advisory
Do not discontinue prescribed antiepileptic, neuroleptic, or psychiatric medications before sample collection without explicit consultation with your managing consultant.
Patient FAQ & Clinical Guidance
1. How accurate is NGS for detecting GRIN1-related mental retardation type 8 compared to older methods?
NGS offers >99.9% analytical sensitivity for single nucleotide variants and copy number variations, vastly outperforming Sanger sequencing by detecting deep intronic and mosaic mutations comprehensively.
2. What exactly is required for the pre-test genetic counselling session under UAE law?
The mandatory pre-test session requires a DHA-licensed counsellor to draw a three-generation pedigree chart and obtain informed consent, compliant with Federal Decree-Law No. 4 of 2016 on Medical Liability for genetic analysis.
3. Can a negative GRIN1 test guarantee that my child does not have a neurological disorder?
A negative GRIN1 definitively rules out autosomal dominant MRD8 but cannot exclude other neurogenetic conditions, requiring further advanced testing like Whole Genome Sequencing for comprehensive diagnosis.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
- Data Protection: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Patient consent and clinical safety protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- DHA Oversight: All genetic testing procedures are conducted under DHA Facility License 1143 and in alignment with Dubai Healthcare City Authority regulations.
Clinical & Logistical Metadata
| Test Name | GRIN1 Gene Sequencing |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA); VIP Mobile Phlebotomy available daily 8 AM โ 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) with full coding region coverage, splice site analysis, and CNV detection |
| ICD-10-CM Code | Q99.8 (Other specified congenital malformations) โ MRD8 |
| LOINC Code | 87673-5 (GRIN1 gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | License 1143 ยท Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE ยท DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["Mandatory pre-test genetic counselling required", "Pedigree chart mandatory for minors per UAE regulations", "Do not discontinue prescribed antiepileptic, neuroleptic, or psychiatric medications without consultation"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians